584 related articles for article (PubMed ID: 25810035)
1. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.
Sakakibara R; Panicker J; Finazzi-Agro E; Iacovelli V; Bruschini H;
Neurourol Urodyn; 2016 Jun; 35(5):551-63. PubMed ID: 25810035
[TBL] [Abstract][Full Text] [Related]
2. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.
Liu Z; Uchiyama T; Sakakibara R; Yamamoto T
Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of bladder dysfunction in Parkinson's disease.
Sakakibara R; Tateno F; Kishi M; Tsuyuzaki Y; Uchiyama T; Yamamoto T
Neurobiol Dis; 2012 Jun; 46(3):565-71. PubMed ID: 22015601
[TBL] [Abstract][Full Text] [Related]
4. Bladder dysfunction in advanced Parkinson's disease.
Winge K; Nielsen KK
Neurourol Urodyn; 2012 Nov; 31(8):1279-83. PubMed ID: 22488851
[TBL] [Abstract][Full Text] [Related]
5. Urinary tract dysfunction in Parkinson's disease: a review.
Yeo L; Singh R; Gundeti M; Barua JM; Masood J
Int Urol Nephrol; 2012 Apr; 44(2):415-24. PubMed ID: 21553114
[TBL] [Abstract][Full Text] [Related]
6. A review of lower urinary tract symptoms in patients with Parkinson's disease.
Badri AV; Purohit RS; Skenazy J; Weiss JP; Blaivas JG
Curr Urol Rep; 2014 Sep; 15(9):435. PubMed ID: 25002072
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
Winge K; Werdelin LM; Nielsen KK; Stimpel H
Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
[TBL] [Abstract][Full Text] [Related]
8. Bladder function of patients with Parkinson's disease.
Sakakibara R; Tateno F; Nagao T; Yamamoto T; Uchiyama T; Yamanishi T; Yano M; Kishi M; Tsuyusaki Y; Aiba Y
Int J Urol; 2014 Jul; 21(7):638-46. PubMed ID: 24571321
[TBL] [Abstract][Full Text] [Related]
9. Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.
Sakakibara R; Tateno F; Yamamoto T; Uchiyama T; Yamanishi T
Clin Auton Res; 2018 Feb; 28(1):83-101. PubMed ID: 29124503
[TBL] [Abstract][Full Text] [Related]
10. Assessment and Management of Urinary Dysfunction in 187 Patients with Parkinson's Disease.
Jia C; Cui X; Yoshimura N; Mao W; Xu E; Wang Q; Ou T
J Parkinsons Dis; 2020; 10(3):993-1001. PubMed ID: 32310185
[TBL] [Abstract][Full Text] [Related]
11. Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction.
Xue P; Wang T; Zong H; Zhang Y
Chin Med J (Engl); 2014; 127(5):878-81. PubMed ID: 24571881
[TBL] [Abstract][Full Text] [Related]
12. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
Bonnet AM; Pichon J; Vidailhet M; Gouider-Khouja N; Robain G; Perrigot M; Agid Y
Mov Disord; 1997 Jul; 12(4):509-13. PubMed ID: 9251068
[TBL] [Abstract][Full Text] [Related]
13. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters.
Sammour ZM; Gomes CM; Barbosa ER; Lopes RI; Sallem FS; Trigo-Rocha FE; Bruschini H; Srougi M
Neurourol Urodyn; 2009; 28(6):510-5. PubMed ID: 19191278
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies.
Brucker BM; Kalra S
Urol Clin North Am; 2017 Aug; 44(3):415-428. PubMed ID: 28716322
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson's disease.
Zong H; Meng F; Zhang Y; Wei G; Zhao H
Clin Interv Aging; 2019; 14():1159-1166. PubMed ID: 31417246
[No Abstract] [Full Text] [Related]
16. Perspectives on the urological care in Parkinson's disease patients.
Moussa M; Abou Chakra M; Papatsoris AG; Dellis A; Dabboucy B; Peyromaure M; Barry Delongchamps N; Bailly H; Duquesne I
Arch Ital Urol Androl; 2022 Mar; 94(1):107-117. PubMed ID: 35352535
[TBL] [Abstract][Full Text] [Related]
17. Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.
Winge K; Fowler CJ
Mov Disord; 2006 Jun; 21(6):737-45. PubMed ID: 16570299
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy.
Ogawa T; Sakakibara R; Kuno S; Ishizuka O; Kitta T; Yoshimura N
Nat Rev Urol; 2017 Feb; 14(2):79-89. PubMed ID: 27958390
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction.
Van Batavia JP; Ahn JJ; Fast AM; Combs AJ; Glassberg KI
J Urol; 2013 Oct; 190(4 Suppl):1495-9. PubMed ID: 23416636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
